BSE filing, NSE: TEJNAKSH. Summary written from the filing by ALFA Finder's alert engine.
Tejnaksh Healthcare Ltd: key numbers
- Share price
- ₹12.69
- Market cap
- ₹25.78 Cr
- Revenue (annual)
- ₹10.79 Cr
- Net profit (annual)
- ₹1.23 Cr
- P/E (TTM)
- 20.8×Sector 53.9×
- Promoter holding
- 73.83%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Tejnaksh Healthcare Ltd
All →Tejnaksh Healthcare Board Meeting Date
Tejnaksh Healthcare will hold a board meeting on 12 November 2026 to consider unaudited Q2 standalone and consolidated results. The filing also notes the trading window closure.
Tejnaksh Healthcare Business Update
Tejnaksh Healthcare's Managing Director Dr. Ashish Rawandale-Patil was selected as a mentor for ES-TIP 2027. The honour is an international recognition of his medical innovation expertise.
Tejnaksh Healthcare Business Update
Tejnaksh Healthcare announced publication of a multicentric validation study of its Pflow device in the Indian Journal of Urology. The filing is a scientific publication update with no financial value.
Tejnaksh Healthcare Other Announcement
Tejnaksh Healthcare Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with Regulation 31(1)(b) of SEBI LODR.
Tejnaksh Healthcare Management Change
Tejnaksh Healthcare shareholders approved the re-appointment of Mr. Suhas Vasantrao Thorat as an Independent Director for a second five-year term at the 18th Annual General Meeting.
Tejnaksh Healthcare Annual General Meeting
The company issued a notice for its Annual General Meeting scheduled for September 29, 2026, to consider financial statements, director appointments, and related party transaction approvals.
Other board meeting date announcements
All →Sahara Maritime Board Meeting Date
Sahara Maritime Ltd intimated BSE of a board meeting on November 13, 2026 to approve unaudited half-year results ended September 30, 2026. The trading window stays closed until 48 hours after results declaration.
Euro Panel Products Board Meeting Date
Euro Panel Products will hold a board meeting on November 14, 2026 for unaudited September 2026 quarter results. The trading window stays closed until November 16, 2026.
Shree Marutinandan Industries Board Meeting Date
Shree Marutinandan Industries will hold a board meeting on 14 November 2026 to approve unaudited standalone and consolidated results for the half year ended 30 September 2026. Trading window is closed from 1 October 2026.
Magson Retail & Distribution Board Meeting Date
Magson Retail rescheduled its board meeting from 7 November to 9 November 2026 to consider half-year results. The trading window stays closed until 11 November 2026.
Promax Power Board Meeting Date
Promax Power scheduled a board meeting for 14 November 2026 to consider half-year unaudited results. The agenda is proposed only, with no figures disclosed.
Ganesha Ecoverse Board Meeting Date
Ganesha Ecoverse Ltd will hold a board meeting on November 14, 2026 to approve unaudited standalone and consolidated half-year results. The trading window stays closed until 48 hours after the results announcement.